Naoki Inagaki Selected Research

1- (2- (1- adamantyl)ethyl)- 1- pentyl- 3- (3- (4- pyridyl)propyl)urea

1/2010

Effects of SA13353, a transient receptor potential vanilloid 1 agonist, on leukocyte infiltration in lipopolysaccharide-induced acute lung injury and ovalbumin-induced allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Inagaki Research Topics

Disease

13	Inflammation (Inflammations) 12/2017 - 05/2002
12	Atopic Dermatitis (Atopic Eczema) 01/2019 - 04/2002
9	Asthma (Bronchial Asthma) 01/2021 - 12/2006
9	Dermatitis 01/2019 - 09/2004
8	Hypersensitivity (Allergy) 01/2021 - 08/2004
4	Food Hypersensitivity (Food Allergy) 04/2019 - 01/2017
4	Allergic Rhinitis 05/2016 - 09/2011
4	Pruritus (Itching) 01/2013 - 09/2006
4	Respiratory Hypersensitivity 10/2012 - 09/2003
3	Anaphylaxis (Anaphylactic Shock) 01/2017 - 09/2010
3	Airway Remodeling 01/2010 - 01/2008
3	Eosinophilia 01/2010 - 01/2008
2	Sneezing 05/2016 - 05/2016
2	Nasal Obstruction 05/2016 - 09/2011
2	Sick Building Syndrome 01/2012 - 06/2011
2	Arthritis (Polyarthritis) 11/2010 - 01/2010
2	Hypoxia (Hypoxemia) 01/2010 - 11/2008
2	Neoplasms (Cancer) 11/2009 - 02/2009
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Vitamin D Deficiency 04/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Egg Hypersensitivity (Egg Allergy) 12/2017
1	Diarrhea 12/2017
1	Mastocytosis 12/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 05/2016
1	Ischemia 08/2013
1	Reperfusion Injury 08/2013
1	Pain (Aches) 01/2013
1	Neurogenic Inflammation 01/2012
1	Rhinitis 01/2012
1	Contact Dermatitis (Eczema, Contact) 01/2012
1	Infarction (Infarctions) 01/2012
1	Stroke (Strokes) 01/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2012
1	Allergic Contact Dermatitis 01/2012

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2019 - 09/2003
10	Immunoglobulin E (IgE)IBA 10/2018 - 09/2006
6	OvalbuminIBA 01/2017 - 01/2010
6	AllergensIBA 07/2012 - 01/2008
5	DinitrofluorobenzeneIBA 01/2012 - 09/2006
4	CytokinesIBA 12/2017 - 08/2004
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2013 - 09/2006
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2010 - 09/2006
3	Immunoglobulin G (IgG)IBA 10/2018 - 01/2010
3	Histamine (Histamine Dihydrochloride)FDA Link 05/2016 - 03/2008
3	Prostaglandin D2IBA 05/2016 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 03/2008
3	LipopolysaccharidesIBA 01/2010 - 04/2002
2	Complex MixturesIBA 05/2016 - 09/2004
2	Substance PIBA 01/2013 - 11/2010
2	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2013 - 09/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013 - 12/2006
2	PeriostinIBA 12/2012 - 07/2012
2	Interleukin-4 (Interleukin 4)IBA 10/2012 - 01/2010
2	Interleukin-13IBA 10/2012 - 11/2008
2	Formaldehyde (Formol)FDA Link 01/2012 - 06/2011
2	Nerve Growth Factors (Neurotrophins)IBA 01/2012 - 06/2011
2	AcetoneIBA 01/2010 - 09/2006
2	SolutionsIBA 01/2010 - 09/2006
2	LeukotrienesIBA 01/2010 - 04/2002
2	cobaltous chloride (cobalt(II)chloride)IBA 01/2010 - 11/2008
2	Group II Phospholipases A2IBA 05/2002 - 04/2002
1	montelukast (Singulair)FDA Link 01/2021
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021
1	LigandsIBA 01/2021
1	Vitamin D FDA LinkGeneric 04/2019
1	CeramidesIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2018
1	Translationally-Controlled 1 Tumor ProteinIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	eppikajutsutoIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	Syk KinaseIBA 08/2013
1	Retinaldehyde (Retinal)IBA 08/2013
1	Toll-Like Receptor 4IBA 08/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013
1	Histamine Antagonists (Antihistamines)IBA 01/2013
1	NeuropeptidesIBA 01/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013
1	Nigella sativa oilIBA 10/2012
1	Interleukin-5 (Interleukin 5)IBA 10/2012
1	IntegrinsIBA 07/2012
1	Prostaglandins DIBA 01/2012
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2012
1	(N- methoxy- N- methyl)- 4- (5- benzoylbenzimidazole- 2- yl)- 3,5- dimethylpyrrole- 2- carboxamide hydrochlorideIBA 09/2011
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 09/2011
1	Xylenes (Xylene)IBA 06/2011
1	TolueneIBA 06/2011

Therapy/Procedure

4	Therapeutics 01/2013 - 12/2006
2	Kampo Medicine (Kampo) 01/2013 - 01/2005
2	Drug Therapy (Chemotherapy) 01/2013 - 11/2009
1	Skin Care 04/2019
1	Immunotherapy 12/2017
1	Oral Administration 01/2013
1	Traditional Medicine (Folk Remedies) 10/2012